The approval of messenger RNA (mRNA) based COVID-19 vaccines marked a pivotal scientific milestone, establishing mRNA as an innovative drug modality with immense therapeutic potential. However, due to ...
Morning Overview on MSN
New lipid nanoparticle design aims for more targeted mRNA delivery
Researchers have developed a new lipid nanoparticle design that directs mRNA to the pancreas by exploiting the organ’s own ...
Que.com on MSN
AI-guided LNP design for targeted in vivo mRNA delivery
Messenger RNA (mRNA) therapeutics have moved from a promising idea to clinical reality, accelerating vaccine development and ...
4d
CD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid Therapeutics
CD Bioparticles announces the launch of comprehensive Extrahepatic RNA Delivery services. NEW YORK, NY, UNITED STATES, ...
Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to ...
Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies
LNP as the novel drug delivery system enhancing mRNA therapeutic efficacy has been proved for its delivery ability. This review provides valuable insights into the current state-of-the-art of LNP mRNA ...
Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results